2,198
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway

ORCID Icon, , , , , , , & show all
Pages 33-41 | Received 27 May 2023, Accepted 03 Dec 2023, Published online: 15 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.